Indications for exercise and pulmonary rehabilitation extend to neuromuscular diseases tough these conditions pose particular challenges given the associated skeletal muscle impairment and respiratory muscle dysfunction. These challenges are compounded by the variety of exercise prescriptions (aerobic, muscle strengthening, and respiratory muscle training) and the variety of neuromuscular disorders (muscular, motor neuron, motor nerve root, and neuromuscular transmission disorders). Studies support a level II evidence of effectiveness (i.e., likely to be effective) for a combination of aerobic exercise and strengthening exercises in muscular disorders, and for strengthening exercises in amyotrophic lateral sclerosis. The potential deleterious effects of work overload in the dystrophinopathies have not been confirmed in Becker muscular dystrophy. Adjunctive pharmacologic interventions (e.g., theophylline, steroids, PDE5 inhibitors, creatine), training recommendations (e.g., interval or lower intensity training) and supportive techniques (e.g., noninvasive ventilation, neuromuscular electrical stimulation, and diaphragm pacing) may result in more effective training but require more study before formal recommendations can be made. The exercise prescription should include avoidance of inspiratory muscle training in hypercapnia or low vital capacity, and should match the desired outcome (e.g., extremity training for task-specific performance, exercise training to enhance exercise performance, respiratory muscle training where respiratory muscle involvement contributes to the impairment).
Introduction
Exercise and pulmonary rehabilitation (PR) have been considered a cornerstone of the management of patients with respiratory problems. 1 While most of the studies concerning the effects of exercise and PR have been performed in patients with chronic obstructive pulmonary disease, the joint statement of the American Thoracic Society and European Respiratory Society recognizes an important role of PR in all patients with respiratory symptoms associated with reduced functional capacity or reduced quality of life. 1 As such, these recommendations could well encompass patients with neuromuscular diseases, although these conditions may pose specific challenges. Specifically, patients with neuromuscular disease may be unable to perform training regimens used traditionally in PR, and appropriate exercise programs may depend on the type of neuromuscular disease, its rate of progression or on the type of exercise. Additionally, there are concerns about the potential harm of exercise for some neuromuscular disease patients. This review will address respiratory manifestations of neuromuscular disease, the pathophysiology and mechanism of exercise limitation in such patients, discuss the concerns of exercise, the potential benefits of rehabilitation and review the mechanisms of benefit of PR (exercise and non-exercise related) in neuromuscular diseases. Finally, specific recommendations for the inclusion of patients with neuromuscular disease in PR programs are suggested.
Respiratory manifestations of neuromuscular disease
Patients with neuromuscular disease and early diaphragmatic or bulbar involvement are vulnerable to the development of respiratory events particularly during exercise and during sleep. Early symptoms of shortness of breath may initially occur only during exertion but may progress to symptoms with activities of daily living, with a tempo of progression that depends on the underlying disease. As patients may unconsciously adjust their activity to reduce fatigue and shortness of breath, early symptoms must therefore be actively sought by specific questions. For instance, since sleep, and more specifically rapid eye movement (REM) sleep, is a particularly vulnerable period for patients with neuromuscular disease, patients may report new onset sleep disturbances, unrefreshed feeling on awakening, morning headaches, disappearance of snoring and development of orthopnea. These symptoms may occur even in the absence of daytime symptoms, although the presence of daytime sleepiness and decreased concentration should also be ascertained. 2, 3 Bulbar dysfunction and impairment of expiratory function in certain neuromuscular disorders may also increase the risk of aspiration. Indicators of bulbar muscle involvement include slurred speech, trouble swallowing liquids (and solids as the disease progresses), aspiration manifesting as a new onset of cough or frank choking spells.
Important features of inspiratory muscle weakness on examination include an increase in respiratory rate, shallow breaths, alternating abdominal and rib cage breathing (respiratory alternans) and paradoxical inward abdominal motion during inspiration (abdominal paradox). 4 
Pathophysiology of respiratory limitation to exercise in neuromuscular disease
Healthy individuals (excluding highly trained athletes) use only about 70% of their maximal voluntary ventilation when maximal oxygen consumption (VO 2 ) and heart rate are reached at the end of a full exercise test. 5 The implication is that even individuals with neuromuscular disease may have well-advanced disease before this reserve is lost and before symptoms develop, even with maximal exercise. Conversely, patients with early or mild non-progressive neuromuscular disease may still be able to achieve normal exercise goals, and be able to appropriately increase ventilation in response to exercise.
Although pulmonary function testing can identify such early respiratory muscle involvement, certain caveats apply and exertional dyspnea may be present despite the absence of restrictive impairment. 6 For instance, the measures of inspiratory muscle strength may be preserved until later in the course of the disease. 7 Additionally, due to the sigmoid shape of the relaxation pressureÀvolume curve of the respiratory system, profound decreases in the respiratory muscle strength may need to be present before total lung capacity starts declining. 6 In addition, functional residual capacity may tend to remain normal in neuromuscular diseases. 8 Formal exercise testing in patients with different neuromuscular diseases may show a common pattern of peripheral and ventilatory limitation, 5 along with disease-specific features such as cardiac limitation (due to deconditioning or associated cardiomyopathy as may be seen with the dystrophies), 9 or early anaerobic threshold as with the mitochondrial myopathies. 10 Specifically, cardiopulmonary exercise testing in patients with diverse neuromuscular diseases generally show a reduction in the maximal oxygen uptake, a reduction in pulmonary ventilation with a possible ventilatory limitation to exercise (as opposed to a normal cardiovascular limitation), a decrease in work capacity or rate and an elevated resting heart rate. 11 These findings may reflect respiratory muscle involvement, cardiac impairment or deconditioning. 11 Eventually, in advanced stages of disease, respiratory muscle weakness causes a restrictive pulmonary impairment which may lead to hypoventilation and hypercapnia. Contributing alterations in respiratory system mechanics include changes in chest and thoracic compliance, hypoventilation, airway secretions and ineffective cough. These alterations result in an increase in the work of breathing, a decrease in the efficiency of gas exchange (with increased ventilation and respiratory rates in order to maintain eucapania), decrease in tidal volumes and ventilation perfusion mismatching. 12 The consequent rapid shallow breathing may be compounded by exercise, thereby increasing the ratio of dead space to tidal volume and further compromising gas exchange. 12 Patients with earlier or less severe neuromuscular disease may still have an adequate ventilatory reserve and may be able to maintain a normal ventilatory response to exercise.
Underlying the vulnerability of breathing during sleep in patients with neuromuscular disease is the development of REM atonia and the normal shift of the burden of respiration to the diaphragm during REM sleep, 13 which may lead to nocturnal desaturation in patients with an impaired diaphragmatic function. 14 Additionally, patients with bulbar involvement may develop hypopneas during REM sleep. [15] [16] [17] Lastly, the withdrawal of the wakefulness drive to breathe during sleep may lead to hypercapnic central apnea. 18 The impact of disrupted sleep on the ability to exercise may be significant. For instance, sleep deprivation in healthy volunteers has been found to have a negative impact on spirometric tests and on muscle endurance, with a decrease in the ventilatory response to hypercapnia. 19, 20 
Specific mechanisms of exercise limitation
In addition to muscle weakness, over 60% of patients with neuromuscular disease complain of severe fatigue. 21 Fatigue is a significant contributor to exercise limitation and encompasses experienced fatigue and physiological fatigue. Physiological fatigue can have both peripheral and central components, depending on whether the limitation is muscular or originates in the central nervous system. 22 Several mechanisms can contribute to this fatigue and exercise limitation, and the combination of mechanisms varies according to the disease in question and severity of disease. In addition to fatigue, there may be disease-specific considerations including potentially deleterious effects of exercise, which may further contribute to exercise limitation in patients with neuromuscular diseases.
Diseases of the motor neuron and chronic overload
This mechanism of limitation has been predominantly discussed in the post-polio syndrome (PPS) but may have parallels in other disorders associated with the loss of lower motor neuron innervation and secondary compensatory axonal sprouting, including amyotrophic lateral sclerosis (ALS), spinal cord injury and cancer-associated motor neuron damage. 23 In the PPS, sprouting from surviving axons reinnervates muscle fibers previously supported by the destroyed motor neuron of the anterior horn cells. This results in a larger muscle mass innervated by a smaller pool of motor neurons. These macro-motor units may be susceptible to failure due to drop out of the chronically overloaded lower motor neurons, loss of their larger subtended muscle mass and dysfunction of the new neuromuscular junction. 24 Similar mechanisms are at play in other disorders in which there is loss of motor neurons such as ALS where there is both evidence of reinnervation leading to an increase in muscle fibers innervated by a single motor neuron 25 and of neuromuscular conduction defects along the reinnervated nerve sprouts. 26 The effect of exercise on loss of stability of these macro-motor units has been documented in a rat model. 23, 27 In those studies, enlarged motor units after partial denervation of a rat hindlimb were found to decrease significantly in size over time, with exercise having the effect of further accelerating the loss of chronically enlarged motor units and reducing the sprouting of extensively denervated muscles. 23, 27 The mechanism by which exercise reduces axonal sprouting may be the inhibition of bridge formation of perisynaptic Schwann cells. 28 These studies implicate time since onset of the disease (whether sprouting is established or ongoing), severity of the denervation and intensity of the exercise, as factors that may have implications in the design of rehabilitation programs in such patients. For instance, whereas normal physiological activity may promote enlargement of the motor unit during the acute phase of sprouting, 23 rehabilitation and exercise immediately after motor neuron injury or in the early stages of motor neuron disease can be potentially detrimental. 23 Dystrophinopathies: Muscle damage and impaired control of blood flow to the muscles Studies have suggested a specific vulnerability of patients with muscular dystrophy to the development of fatigue and muscle damage with exercise. For instance, Belanger et al. measured ankle plantarflexor and dorsiflexor-evoked and voluntary contractile responses in patients with muscular dystrophy. Their results indicate greater weakness on the preferred lower limb (as assessed by the extremity used when patients were asked to kick a ball) compared to the non-preferred side, thereby providing some evidence for potential harmful effects of overwork of dystrophic muscles. 29 In studies of an animal model of Duchenne muscular dystrophy (DMD) (the mdx mouse model), a twice weekly exercise for 30 min on a speed treadmill decreased hindlimb muscle strength. 30 Apoptotic damage has also been demonstrated in mdx mice subjected to exercise 31 and mdx muscle has been shown to have a delayed rate of pH recovery following isometric exercise. 32 Because of these concerns, some authors have supported submaximal exercise in patients with muscular dystrophy. 33 In that regard, studies in both humans and in animal models have focused on the roles of nitric oxide (NO), vascular supply and dystrophin in the exercise impairment of muscular dystrophy. These roles are not necessarily mutually exclusive as nitric oxide synthase (NOS) is complexed with the dystrophinglycoprotein complex. 34 The studies described below provide a framework for a model of muscle injury with exercise in certain muscle dystrophies whereby loss of the membrane-stabilizing effects of dystrophin may result in direct mechanical damage to the muscles. Secondary muscle inflammation may be perpetuated or aggravated by the loss of NO-mediated anti-inflammatory effects. 35 Additionally, in such patients, exercise may promote both fatigue and progressive muscle fibrosis when nNOS-deficient muscles are subjected to repeated bouts of ischemic exercise. [36] [37] [38] This problem can be compounded by the finding that, in the mdx mouse model, muscle fibrosis was found to involve the diaphragm, further impairing exercise and respiratory ability. 39 Impaired NO maintains the vasoconstriction induced by sympathetic activation. NO produced by skeletal muscle neuronal nitric oxide synthase (nNOS) regulates blood flow and oxygen delivery in exercising skeletal muscle by preventing the vasoconstrictor response to sympathetic activation. 40 There is much evidence that neuronal nNOS is missing or reduced from its sarcolemmal location in muscle cells in both Duchenne 41 and Becker 42 muscular dystrophies. For instance, in a study of sarcolemmal nNOS on muscle biopsies of 425 patients with various muscle diseases, nNOS staining was found to be absent or reduced in all those with Duchenne and Becker muscular dystrophies, and in 73% of those with other muscle disorders subsuming limb-girdle muscular dystrophy, congenital muscular dystrophies, myositis and myopathy. 38 This study suggests a common mechanism of fatigue in these neuromuscular diseases. Sander and colleagues used near infrared spectroscopy to measure changes in tissue oxygenation induced by reflex sympathetic activation in resting and exercising skeletal muscles of children with DMD. 36 In that study, the vasoconstrictor response to sympathetic activation resulted in unopposed vasoconstriction (as measured by a decrease in muscle oxygenation) during exercise of dystrophic muscles. In contrast, vasoconstrictor response to sympathetic activation was prevented in healthy children and those with polymyositis or limb-girdle muscular dystrophy. 36 In another study, researchers examined physical activity levels in normal mice, in mdx mice (a model of DMD) and in Sgca-null mice (a model for a limbgirdle muscular dystrophy type 2D) before and after a mild treadmill exercise. The dystrophic mouse lines had sarcolemmal nNOS deficiency. Although all the mice displayed normal activity before exercise, only those dystrophic mice with nNOS deficiencies had significantly less activity post-exercise, with imaging studies showing corresponding vascular narrowing in the skeletal muscle which were not present preexercise. 38 The central role of NO in preserving muscular function is further reinforced in a study of skeletal muscle function in nNOS knockout mice, which showed that nNOS-deficiency caused a myopathy (reduction in skeletal muscle bulk and maximum tetanic force production) in male mice, and contractioninduced fatigue in male and female mice. 43 These results replicate clinically important features of the dystrophinopathies and suggest a particular vulnerability of males to the development of myopathy, heightened by the fact that males are predominantly affected by the X-linked recessive dystrophies (Duchenne and Becker dystrophies). Impaired NO production leading to a proinflammatory response. NO also has cytoprotective and anti-inflammatory properties, and reduced NOmediated inhibition of macrophage diapedesis in mdx mice may result in the release of cytolytic molecules that contribute to muscle damage. 35 In one study, 4week mdx mouse muscle was found to contain high concentrations of macrophages, central-nucleated muscle fibers and a high variability in muscle fiber diameter. Evidence of reduced muscle damage was found in mdx mice that had their NO production restored by cross-breeding with NOS transgenic mice, along with a reduction in macrophages and cells expressing major histocompatibility complex class II (MHC-II). The pathogenic role of macrophages was established by finding that mdx muscle macrophages at pathophysiological concentrations were able to lyse muscle cells. 35 The promotion of inflammation and necrosis may be through NF-kB signaling in the recruited macrophages, 44 and in an mdx mouse model, curcumin, a potent NF-kB inhibitor, was found to improve sarcolemmal integrity and reduce structural defects in myofibrils. 45 Loss of the membrane-stabilizing effects of dystrophin. Dystrophin (a structural protein found in small amounts in normal muscle but absent or defective in muscular dystrophy) is reported to have membranestabilizing effects on the subsarcolemmal membrane, thereby protecting the muscle fibers from potentially damaging tissue stresses during muscle contraction (the mechanical defect hypothesis). 46 The absence of dystrophin in patients with DMD may predispose these patients to damage during exercise. 46 Implications for treatment. These insights gained from the mouse models provide opportunities for the prevention of muscle injury and fatigue with exercise in patient with dystrophies. Restoration of sarcolemmal nNOS expression in dystrophic muscles and of the NOS signaling pathway appear to be an important potential avenue of treatment which can be addressed by either gene therapy or medications. 38, 43 For instance, the normalization of NO production in mdx mice (by cross-breeding with NOS transgenic mice) reduced muscle pathology and decreased serum creatine kinase concentration in mdx mice. 35 In addition, treatment of nNOS-deficient mice with tadalafil or sildenafil, both phosphodiesterase 5 (PDE5) inhibitors and NO effectors, significantly alleviated the post-exercise fatigue response in these mice. 38 Further studies are needed to determine whether there is a potential therapeutic role for these agents in human dystrophies.
A potential role of anti-inflammatory drugs is also suggested by the above data. Whereas steroids induced apoptosis in the muscle of free-living mice, they prevented apoptosis caused by exercise loading in mdx mice. 31 The benefits of systemic steroids in improving average muscle strength scores of boys with DMD has been established in a randomized trial, although with the expected side effects of these agents. 47 However, neither deflazacort (a prednisolone derivative) nor ibuprofen improved postexercise activity in mdx mice. 38 
Mitochondrial dysfunction
The normal functioning of muscles depends on intact mechanisms of oxidative metabolism, particularly mitochondrial function. For instance, the degree of exercise intolerance in the mitochondrial myopathies correlates directly with the impairment in muscle oxidative phosphorylation. 48 While myopathies and neuropathies are common in mitochondrial diseases, 49 the converse is also true as mitochondrial dysfunction has been associated with certain neuromuscular disorders both as a direct pathogenetic mechanism to the disease, 50 and as a factor contributing to the exercise limitation. Mitochondrial dysfunction is thought to play a role in zidovudine-associated myopathy, 51, 52 inclusion-body myositis, 53 Friedrich's ataxia, 54 ALS 50,55 and DMD. 32 There is much evidence for mitochondrial damage of the central nervous system in patients with ALS. 50 Whether this translates into mitochondrial dysfunction of skeletal muscles is unclear, and may depend on the clinical severity of the disease. For instance, in a study of 11 patients with ALS able to participate in an incremental bicycle exercise, lactate production was increased relative to controls, with an anaerobic threshold lower than that of normal subjects and non-ALS denervated controls with similar motor impairment. 56 In contrast, in a careful study of mitochondrial function in patients with early stage spontaneous ALS, Echaniz-Laguna et al. showed no evidence of mitochondrial dysfunction. 50 Specifically, in this study, ALS individuals had similar maximal VO 2 on maximal exercise stress testing, similar muscle oxidative capacity on muscle biopsy specimens and no evidence for mitochondrial respiratory complex II or cyclooxygenase (COX) enzyme disruption compared to sedentary controls. 50 The discrepancy is likely due to the shorter mean duration of the disease (9 months) and the selective process of matching the physical activity of ALS patients to controls in the latter study. 50 For instance, mitochondrial dysfunction as assessed by lactate stress testing has been reported to be present in half of the ALS patients and to be related to the clinical severity of the disease as assessed by the Norris score. 55 An impairment of mitochondrial metabolism may also be possible in DMD. In a nerve stimulation study of mdx mice, Dunn et al. found a reduction in the maximal activities of the oxidative enzymes succinate dehydrogenase and succinate-cytochrome c reductase suggesting impaired mitochondrial metabolism. 32 
Abnormal muscle metabolism
The metabolic myopathies often present with exercise intolerance (rather than fixed weakness) and include glycolytic/glycogenolytic disorders, and disorders of lipid metabolism (enzymatic defects of b-oxidation, carnitine deficiency or defects of fatty acid transport). In these cases, the limitation in exercise tolerance can be attributed to the underlying defect in muscle metabolism with subtle clinical differences between those disorders. For instance, patients with defects of glycogen metabolism can have easy fatigability and muscle stiffness with exercise (either brief isometric exercise, or less intense but more sustained dynamic exercise), which can improve after muscle rest, whereas patients with disorders of lipid metabolism have symptoms after prolonged exercise, without muscle cramps and without improvement after brief rest. 57 Abnormalities in muscle metabolism are not limited to the myopathies. For instance, ALS patients were also demonstrated to have abnormalities in plasma and muscle lipid metabolism during exercise with reductions in exercise-induced plasma-free fatty acids, b-hydroxybutyrate, esterified carnitine and muscle esterified carnitine. 58 
Impaired muscle activation
In ALS, fatigability during isometric exercise of the tibialis anterior muscle was demonstrated, with greater declines in maximum voluntary and tetanic force with repeated efforts as compared to healthy controls. 59 The noted fatigue was not central and was not due to failure of neuromuscular transmission. Rather, impaired energy metabolites and proton signal intensity tended to be less in ALS patients compared with controls, suggesting impaired muscular activation rather than a metabolic impairment. 59 Similarly, in a study of the fatigability and metabolism of the anterior tibialis muscle with isometric exercise in patients with the PPS, there was greater fatigability, delayed recovery without change in metabolic parameters (intracellular pH and phosphocreatinine) compared to controls, suggesting that the fatigue was due to impaired activation beyond the muscle membrane. 60 
Central activation failure
In a study of patients with facioscapulohumeral dystrophy (FSHD), myotonic dystrophy (DM) and hereditary motor sensory neuropathy (HMSN), a large central activation failure was present compared to controls (36-41% vs 12%, respectively). Central activation failure is the fraction of maximal possible force (generated during a sustained maximal voluntary contraction) that is not activated voluntarily. It is determined by measuring the incremental force obtained with electrical stimulation. For instance, in the absence of a central activation failure, no additional force would be expected by electrical stimulation. 61 This central activation failure correlated with the level of experienced fatigue, and physiological fatigue (which encompasses central and peripheral components) was proposed as an important contributor to exercise limitation in neuromuscular disorders. 22 A contribution of central factors in the generation of muscle fatigue was also suggested in patients with ALS. For instance, at the end of exercise consisting of intermittent submaximal isometric ankle dorsiflexion, ALS patients but not normal controls, had an incremental force generated in response to a stimulus train superimposed during a maximal voluntary contraction, indicating significant central fatigue in ALS. 62 
Exercise training in neuromuscular diseases

Types of exercise training and their benefits
The types of exercise training used most commonly in patients with neuromuscular diseases include aerobic exercise, muscle strengthening exercises and specific respiratory muscle training. A recent systematic review of exercise therapy in patients with neuromuscular diseases addressed the effectiveness of these different modalities of training in motor neuron disorders (such as post-polio), motor nerve root (such as HMSN) or peripheral nerve disorders (such as chronic peripheral neuropathy), neuromuscular transmission disorders (such as myasthenia gravis [MG]) and finally muscle disorders (such as dystrophies, myopathies, myositis). 63 Ratings of effectiveness included a review of randomized clinical trials, controlled clinical trials and other designs such as prepost studies, but excluding case studies. 63 In that review, a combination of aerobic exercise with strengthening exercise in patients with muscle disorders was given a level II evidence of effectiveness (i.e. likely to be effective), whereas aerobic exercise alone was given a level III evidence of effectiveness (i.e. indications of effectiveness). 63 Additionally, breathing exercises were given a level III evidence for patients with MG and for patients with myotonic muscular dystrophy. 63 Otherwise, that review indicated an insufficient level of evidence to determine the effectiveness of aerobic exercise, muscle strengthening exercises or breathing exercises for patients with non-muscle disorders such as motor neuron disorders, motor nerve root or peripheral nerve disorders, 63 though a more recent review assigned a level II evidence for muscle strengthening in ALS. 64 These findings and training-specific recommendations are summarized in Table 1 .
Cardiovascular (aerobic) exercise
Several studies have shown that patients with diverse neuromuscular disorders have cardiovascular adaptations to exercise compared to those of normal healthy individuals. 58, 69, [71] [72] [73] [74] [75] [76] [77] [78] [79] Muscular disorders. The weight of evidence suggests that the greatest benefits of aerobic training are predominantly seen in patients with muscular disorders (subsuming various dystrophies, myopathies, myositis, as opposed to other neuromuscular disorders). 63, 72 For instance, studies in patients with muscular disorders have generally adopted walking, cycling or treadmill exercise protocols with workload at a target 50-85% of the predicted maximal heart rate, for about 15-45 min per session, 2-4 sessions per week for 8-18 weeks. 65 Overall benefits consist of 11-22% improvements in activities of daily living (ADL) scores, 5-20% reduction in mean exercise heart rate, 5-30% increase in mean maximal VO 2 , with no evidence of change in creatine kinase levels, and with reduction in lactate level. 65 As far as quality of life indices are concerned, aerobic exercise training was associated with a 25% improvement in subjective handicap assessment and near normalization of the SF-36 health summary score. 79 Unfortunately, these studies generally included patients with diverse muscular disorders, raising the concern that these protocols may have diluted potential deleterious effects of exercise in patients with dystrophinopathies. For instance, a differential effect by condition is suggested in a study showing that the short-term benefits of an aerobic training program were predominantly seen in patients with mitochondrial myopathies and not in those with nonmetabolic myopathies (with a predominance of diverse dystrophies). 74 This differential effect was perhaps also seen in the effects of exercise on the quality of life and activities of daily living, with a 28% increase in patients with mitochondrial myopathies and an 18% increase in the SF-36 overall score in patients with non-metabolic myopathies (in which dystrophies were highly represented). 74 Most of the studies of training effects in patients with DMD addressed strength training rather than aerobic training. 80 To our knowledge, there is one study on the effect of aerobic training in patients with Becker muscular dystrophy (BMD), which specifically addressed the concern of exercise in dystrophinopathies. 80 That study included 11 patients with BMD and 7 matched controls subjected to 50 30-min exercise sessions at 65% of maximal oxygen uptake, over a period of 12 weeks. The patients had a 47% improvement in maximal VO 2 that was higher than that seen in healthy subjects, and that was maintained after 1 year of training. There was no evidence of myoglobinuria, and no increase in creatine kinase levels. Furthermore, muscle biopsies showed no effect of training on necrotic and apoptotic fibers, and no change in regeneration in new and old fibers. 80 These findings may be specific to patients with BMD who have better functioning dystrophin compared to DMD. In a mouse model of dystrophy, fatigue and contractility properties of diaphragm and soleus were not altered by wheel running in mdx mice compared to control mice, except for increased contraction time in diaphragm contraction in mdx mice. 81 Motor neuron disease. Only a few studies address the role of aerobic exercise in patients with more rapidly progressive neuromuscular diseases such as ALS. 56, 58, 69 One of those studies shows that patients with ALS can achieve maximal effort during exercise but with a decrease in the maximal VO 2 that is proportional to the decrease in the ALS functional score, and with a higher oxygen cost for the same level of submaximal work as controls. 71 Other studies show that exercise in these patients results in increased lactate and lipid peroxides, with a reduced anaerobic threshold. 56 In a study that used non-invasive ventilation during exercise in patients with ALS, an exercise program improved the quality of life on the functional independent mobility scale, 82 but not in the Barthel scores. 69 None of these studies address the effects of an aerobic training program on exercise capacity in ALS, and given the paucity of human studies on the topic, Chen and colleagues reviewed animal studies of exercise in SOD1 mice (an animal model of ALS). 64 Their review concluded that there may be an inverse relationship between survival and exercise intensity, with lower treadmill speeds (3.4-16 m/min) improving survival and more intense exercise (22 m/min) resulting in decreased survival. 64 However, the authors also emphasized that even prolonged exercise may not necessarily be associated with a survival disadvantage, provided exercise periods are alternating with regular rest periods. 19, 83 Note that these results concord to some extent with the studies reviewed above on the effect of exercise on the stability of macromotor units. 23, 27 Studies in the PPS show that an aerobic exercise program can improve the energy cost of walking, walking duration and maximum VO 2 , without untoward events or loss of leg strength. 84, 85 Those studies were not considered to provide sufficient evidence as to the effectiveness of aerobic exercises in the PPS. 63 Other neuromuscular disorders: Motor and sensory neuropathy. In a 12-week training program (6 sessions of 5-min bouts of exercises with a cycle ergometer adjusted to reach 70% of maximal VO 2 ), 8 patients with slowly progressive or non-progressive neuromuscular disorders were associated with a 25% increase in maximal VO 2 . 72 Although the expected heart rate reductions were delayed or nonexistent in the two patients of this group with HMSN, 72 another study of 8 patients with HMSN showed no change in isometric force production after 24 weeks of an interval cycling exercise training, but there were significant improvements in cardiorespiratory capacity (increase in VO 2 ), isokinetic concentric strength (knee extension and flexion) and functional ability measurement (descending/ascending stairs, chairs and walking). 73 The exercise consisted of three nonconsecutive sessions per week, each lasting 45 min, including a 5-min warm-up followed by 6 sessions of 5-min exercise bouts: 4 min at 40% of initial maximal aerobic power (P max ) alternating with 1 min at 80% of P max . 73 
Strength training
Strength training is an important component of PR in patients with neuromuscular disease, and is often used in conjunction with aerobic endurance training. As mentioned earlier, the combination of aerobic exercise with strengthening exercise in patients was given a level II evidence of effectiveness for patients with muscle disorders. 63 However, an evidence-based review indicated that there was insufficient evidence for the effectiveness of strengthening exercises alone in patients with muscle disorders, motor nerve root disorder, peripheral nerve disorder and motor neuron disorder. 63 Strength training to improve cough effectiveness. Notwithstanding the above, one concrete application of upper extremity strength training may be to improve cough in patients with impaired expiratory muscle function. 68 For instance, defective coughing in tetraplegics may be attributed to loss of motor innervation of expiratory muscles from injured thoracic and lumbar cord segments. 86 However, some tetraplegics can effectively cough, perhaps because of preserved function of proximal muscles that contribute to expiratory muscle function, such as the pectoralis major (particularly its clavicular head) 87, 88 and the latissimus dorsi. 88 In one study, training the pectoralis major muscles by repetitive, strenuous, isometric and symmetric contractions of the upper extremities for 6 weeks was shown to improve the pectoralis major strength, and to increase in the expiratory reserve volume (indicating improved expiratory muscle strength). 68 Muscular disorders. In two evidence-based reviews, despite the absence of adverse effects (especially in DM and FSHD), there was insufficient evidence to recommend strengthening exercises for muscular disorders due to insignificant or inconsistent effects. 63, 89 The protocols of the reviewed studies consisted generally of knee extension and or flexion, elbow flexion, hip abduction and extension, with 4-20 repetitions for 1-5 sets, 3-4 times per week, over 9-12 weeks. 65 The level of resistance used was variable at 30-70% of maximal voluntary contraction. 65 All of those studies generally report improvement in muscle strength, 65 including the dystrophies such as DMD, [90] [91] [92] and FSHD. 93 These studies generally showed improvements in muscle strength for programs lasting 1-3 months. 65 Additionally, improvements in the quality of life can be seen independently of the objective strength benefits. For instance, strength training in patients with DM was associated with improvement in the quality of life on a global self-assessment questionnaire yet with no clear objective changes in strength, whereas patients with HMSN undergoing the same training had no significant change on the global assessment items, despite greater objective improvement in strength. 94 In addressing the specific concern of muscular injury with exercise in muscular disorders, lengthening (eccentric) exercises have generally been considered potentially more detrimental than shortening (concentric) exercises. [65] [66] [67] Motor neuron disease. A comprehensive review of controlled trials found insufficient evidence for the effectiveness of strength training in motor neuron disorders such as the PPS and ALS, but this review did not specifically address quality of life measures. 63 Conversely, in a review of human and animal studies, muscle strengthening exercise was considered more likely to be beneficial than deleterious in patients with ALS, provided the exercise is individualized, monitored and with progressive resistance. 64 The two randomized human studies on which this recommendation is based are reviewed here. 95, 96 In a 6-month study of adults with early stage ALS, subjects randomized to a resistance exercise group had significantly higher ALS Functional Rating Scale (ALSFRS; a validated functional scale for patients with ALS), improved upper and lower extremity subscale scores and improved SF-36 physical function subscale scores, with no adverse events. 95 Similarly, in an individualized exercise program involving most muscle groups of the four limbs and trunk, subjects randomized to exercise had less deterioration on the ALSFRS and on the Ashworth spasticity scale at 3 months, yet with no changes in manual muscle testing (MMT), fatigue severity scale or SF-36. 96 These benefits were not seen at 6 months. 96 In a muscular resistance training program, patients with the PPS underwent 2 sets of 10 repetitions/ machine (including cable rear pull downs, knee extensions, arm presses and thoracic/lumbar rotation), 3 days/week for a total of 12 weeks. The study showed improvements in muscle strength, muscle endurance and in quality of life as assessed by mental health on the SF-36. 97 Other neuromuscular disorders. There is a paucity of data regarding strengthening exercises in motor nerve root disorders and peripheral nerve disorders. There is some evidence that there may be differential effects of training by condition. For instance, in a comparison of weight training exercise of the proximal lower extremity muscles among patients with DM and HSMN, Lindeman and colleagues found no signs of deterioration in either group, though there was no discernible training effect in the DM patients, and increased knee torques in the HMSN group. 94, 98 In other studies of patient with HMSN, exercise training increased type I muscle fiber diameter, strength and ADL, with no additional benefits with creatine supplementation. 99, 100 
Respiratory muscle training
The role of respiratory muscle training in improving exercise performance and sensation of dyspnea in patients with neuromuscular disorders is controversial. 70 Important factors that may determine whether such training will be of benefit include the specificity of the training to the impairment, the intensity of the training as well as severity and nature of the underlying neuromuscular disease.
As far as the specificity of training is concerned, respiratory muscle training may be of greatest benefit in patients in whom respiratory muscle weakness or fatigue is contributing to the impairment, as opposed to those in whom the exercise limitation is due to cardiovascular or limb impairment, and for which more general training may be preferred. 70 Training improvement in inspiratory muscle performance is more pronounced in less severely affected patients and may not be expected to be helpful in the severely impaired individuals, those who are already hypercapnic or those with more rapidly progressive neuromuscular diseases. 70 For instance, Winkler et al. showed dose-dependent benefits of inspiratory muscle training in patients with neuromuscular disease, but only in those with slowly progressive disease. 101 For instance, breathing through inspiratory resistive loads in ALS (a more rapidly progressive disorder) results in worsening maximal inspiratory pressures, vital capacity and peak inspiratory flow rates. 102 Interestingly, those changes were reversed with theophylline, 102 and aminophylline was found to improve the endurance of respiratory muscles in ALS. 103 In patients with DMD, respiratory muscle function parameters improved significantly after 1 month of inspiratory muscle training with further improvements after 3 and 6 months. The benefits persisted even 6 months after the end of training. However, some patients with hypercapnia or a FVC < 25% had no improvement. 104 Similarly, Koessler et al. assessed the effect of inspiratory muscle training in patients with DMD and spinal muscular atrophy. 105 The training consisted of breathing maneuvers against variable inspiratory resistance for endurance, and of maximal inspiratory efforts against a nearly occluded resistance for strength training. The training was maintained for about 2 years and the authors document improvement in maximal inspiratory pressures, and maximum voluntary ventilation (a reflection of endurance) and no decline in vital capacity over the 2 years of the study. 105 These findings differ somewhat from those of another study of specific respiratory muscle training in 18 boys with DMD with results indicating an improvement in ventilatory muscle endurance but not in strength. 106 Methodological differences, with greater length and intensity of training in the former study, may account for those differences.
Pursed lips breathing and deep breathing were found effective in improving tidal volume, minute ventilation, oxygen saturation and reducing respiratory rate in subjects with myotonic muscular dystrophy, possibly from the reduction of the end-expiratory lung volume, and/or improvement in inspiratory volume and expiratory rib cage muscle recruitment. 107 Home-based inspiratory muscle training, diaphragmatic breathing and pursed lips breathing were evaluated in a randomized control trial of patients with MG. 108 Although subjects in the training group had no change in lung volumes, significant improvements were demonstrated in respiratory muscle strength, in chest wall mobility, endurance and respiratory patterns. 108 Improved quality of life in the role of the physical domain of the SF-36 was also noted. 108 Adjunctive techniques to support respiratory function during exercise in patients with neuromuscular diseases Non-invasive ventilation. An important caveat in the applicability of exercise training in patients with neuromuscular disease is that the illness itself may preclude exercise to a level that can lead to cardiovascular benefits. For instance, Florence et al. limited their study to patients with slowly or nonprogressive neuromuscular disease, 72 and Sanjak et al. suggest that the success of neuromuscular adaptation exercise in patients with ALS may depend on the degree of motor neuron involvement 71 Similarly, the benefits of inspiratory muscle training were seen in those patients in whom the respiratory muscle involvement was only slowly progressive. 101 Of particular concern is the possibility that respiratory involvement from the disease and that hypoventilation (both nocturnal and daytime) may be at least partly responsible for the cardiovascular deconditioning associated with neuromuscular disorders. In that regard, non-invasive ventilation has been shown to effectively support ventilation and improve survival in patients with ALS 109, 110 by mechanisms unrelated to improvement in rate of decline of lung function and unrelated to improvements in the respiratory muscle strength. 111 Pinto et al. extended these data by combining a regular regimen of treadmill exercise with non-invasive ventilatory support (administered for 30 min prior to exercise) in 8 patients with ALS. 69 Compared to a control group of ALS patients, the ALS patients undergoing exercise after non-invasive ventilation had a slower rate of decline of lung function (forced vital capacity [FVC]), improvements in functional mobility (measured by the Functional Independence Measure scale 82 ) and a slower clinical course (Spinal Norris Score). 69 Similar findings were found in other studies of restrictive 112, 113 and obstructive 114, 115 pulmonary impairments. For instance, in a study of severe restrictive pulmonary disease with hypercapnia (including patients with post-polio but excluding patients with progressive neuromuscular disease), non-invasive ventilation during exercise was associated with an increase in the duration of exercise at a constant work load in 50% of patients, with corresponding reduction in heart rate and oxygen desaturation and improved dyspnea relief during exercise. 112 In a systematic review of studies for patients with chronic obstructive pulmonary disease, non-invasive ventilation during exercise reduced exertional dyspnea and improved exercise endurance. 116 In contrast, one study showed that although non-invasive ventilation during exercise improves minute ventilation in patients with severe scoliosis, exercise endurance was not improved and perhaps even reduced by the use of mouthpieces or ventilation. 117 The authors proposed that there may be limitations to exercise in patients with severe scoliosis that are unrelated to ventilatory impairment. 117 Neuromuscular electrical stimulation. Another technique to compensate for the intrinsic limitation of the neuromuscular disease and allow treadmill walking is the use of neuromuscular electrical stimulation and partial body weight support in incomplete tetraplegics, which was shown to improve physical capacity including maximal VO 2 . 118 Neuromuscular electrical stimulation has been used in other disorders as well, including recovery from stroke. 119 Its role if any in the degenerative neuromuscular diseases is unknown. It may prove to be a useful training method at least in some patients, perhaps those with the greatest degrees of ventilatory limitation.
Diaphragm pacing. Diaphragm pacing is a potential option to support ventilation during exercise in patients with neuromuscular disease. This can be achieved with phrenic nerve stimulation, either through a thoracotomy, phrenic nerve dissection and implantation of phrenic nerve electrode, 120 or, less invasively, through intramuscular diaphragm electrodes implanted near the phrenic nerve motor points via laparoscopic surgery. 120 These types of devices have been used predominately in patients with intact phrenic nerves, and a laparoscopic motor point diaphragm pacer received approval from the Food and Drug Administration (FDA) for spinal cord injury patients for whom a traditional aerobic exercise program may be difficult to achieve. [120] [121] [122] However, there are ongoing studies of the device in ALS patients in whom the lower motor neurons (and therefore phrenic nerve function) may be impaired. Extending the use of diaphragm pacing beyond its original indication of spinal cord injury may therefore expand its application to exercise, although much remains to be determined in that regard.
Mechanisms of improvement
Proposed mechanisms for improvement in exercise tolerance resulting from exercise training in patients with chronic respiratory disease such as chronic obstructive pulmonary disease (COPD) include improvements in body composition with increase in fat-free mass, balancing of fiber type proportion, increases in fiber cross-sectional area with proportional increase in capillary contacts, increases in the capacity of oxidative enzymes, decrease in lactic acidemia and increase in oxidized glutathione. 1 Some of these beneficial effects have been duplicated in patients with neuromuscular diseases, with additional findings specific to those conditions.
In a study of a patient with HMSN, resistance training was found to increase type I muscle fiber diameter and strength, as well as improve activities of daily living. 99 Although supplemental dietary creatine was not found to improve muscle performance or muscle fiber size above that found with resistance training alone, 99 one morphologic study showed that creatine increased myosin heavy chain type II in HMSN patients undergoing resistance training, and that these changes correlated with improved muscle function as measured by chair rise time. 123 Another study of patients with HMSN showed that the initial strength increase with resistance training could be attributed to improved recruitment of motor units, with a subsequent contribution from muscle hypertrophy. 98 These findings were not replicated in DM. 98 Resistance training in rats was found to remodel the neuromuscular junction structure such that there was increased endplate perimeter length and area and enhanced dispersion of acetylcholine receptors, 124 which cannot be attributed to muscle fiber hypertrophy or fiber type conversion. Whether these changes could explain potential beneficial effects of resistance training in patients with neuromuscular diseases affecting the neuromuscular junction remains to be determined.
Exercise could also be beneficial at a more central level, and was found to promote neurogenesis in the dentate gyrus of exercising mice. 125 In an animal model of ALS, regular treadmill exercise had a beneficial effect on the progression of ALS in G93A-SOD1 transgenic mice, a model of familial ALS. 126 A significant gender difference was noted, such that the survival benefit was seen only in male mice, suggesting that testosterone levels may play an important role. 126 Such a beneficial effect may be disease specific as free testosterone was found to be reduced in ALS. 127 
Exercise prescription
No formal evidence-based guidelines exist for exercise training of patients with neuromuscular disease. However, some general recommendations can be proposed based on the available literature. The benefits of exercise therapy involving aerobic training have best been established in patients with muscular disorders (subsuming diverse myopathies and muscular dystrophies). 63, 65 While the evidence is more limited for motor neuron disorders, disorders of neuromuscular transmission, motor nerve root or peripheral nerve disorders, this does not preclude a benefit of an exercise intervention for patients with those conditions. 69, [71] [72] [73] 128 In selecting patients for an exercise program of respiratory muscle training, strength training or aerobic exercise, one should consider the patients' limitations. For example, inspiratory muscle training may not be beneficial in patients who are already hypercapnic, 70, 104 or have a vital capacity < 25% predicted, 104 and cardiovascular training may be difficult to achieve in patients with significant limb weakness. Additionally, several of the neuromuscular disorders, the dystrophies in particular, may be associated with cardiac impairment, and training in those conditions should proceed with caution and close supervision. 80 Consequently, an initial assessment for candidacy to such programs may need to include a pulmonary evaluation with spirometry and arterial blood gases, and a cardiac evaluation to include an electrocardiogram (EKG) and possibly an echocardiogram, particularly for the patients with dystrophies. Whereas cardiopulmonary exercise testing may help determine whether the exercise limitation is cardiac, pulmonary or due to deconditioning, a full cardiopulmonary exercise test may be difficult to achieve in patients with limb weakness, and is probably not necessary in order to reach an exercise prescription. Rather, an individualized exercise program should match the patient's limitation and should be tailored to the desired outcome. For example, respiratory muscle training should be considered in patients in whom respiratory muscle weakness or fatigue is contributing to the impairment, 70 extremity training should aim to enhance task-specific performance 129 and exercise training to improve exercise performance. 1 Additionally, regular supervision is recommended to optimize the effects of the training, and improve safety. 63 As is true for PR for patients with other forms of chronic respiratory disease, 1 exercise rehabilitation for patients with neuromuscular disorders could aim for relatively long (about 30 min or more) walking treadmill or cycling exercise sessions at high levels of intensity (about 60% maximal heart rate). 72 For the more limited and symptomatic patients, interval training with shorter smaller exercise sessions alternating with rest periods and lower intensity training may also achieve gains in exercise tolerance. 1 While this recommendation is predominantly based on studies in patients with no neuromuscular disease, there is one study applying interval training to patients with HMSN. 73 Animal studies have also used training alternating with rest in a mouse model of ALS. 83 Programs applied in patients with myopathy and chronic respiratory diseases such as COPD have usually consisted of 12-48 sessions (with recommendations for at least 20), given 2-4 times per week (recommendations for at least 3 times per week), over 8-18 weeks. 1, 72 Following completion of the program, a maintenance program may be necessary, as training benefits persist only for as long as the exercise is maintained. 129 Monitoring for deleterious effects with exercise could include measurements of creatine phosphokinase (CPK) or urine myoglobin as has been performed in patients with dystrophies. 80 In patients prone to the development of associated cardiomyopathies, a cardiac evaluation and optimal medical management of identified impairment should be started before participation in an exercise program. Motor unit number estimation (MUNE) is an electrophysiologic approach that provides a numeric estimate of the number of axons innervating a muscle or group of muscles, 130 but whether this would be a sensitive endpoint measure for studies of exercise in ALS or other motor neuron diseases remains to be determined. A patient with HMSN may develop diaphragm dysfunction due to phrenic nerve impairment, 131 which should be evaluated before participation in an exercise program. Patients with myasthenia could have rapid deterioration with exercise and should be on optimal medical management before participation in an exercise program ( Table 2) .
Respiratory muscle training is best reserved for patients in whom respiratory muscle weakness or fatigue contributes to their impairment yet without hypercapnia or severe pulmonary restriction. 70 In addition to the importance of directing respiratory muscle training to patients with respiratory muscle involvement from their disease, there may be important aspects to the type of training. For example, respiratory muscle training could consist of resistive, hyperpneic or threshold loading. Exercise-induced hyperpnea represents flow loading, and training in that regard could include either voluntary isocapnic hyperpnea (which is predominantly a flow-loading type of training) or threshold load training (which has been more frequently studied and may train both the pressure and flow-generating capacity of respiratory muscles). 70 Interventions that may facilitate or enhance the effects of exercise in patients with neuromuscular disease include provision of non-invasive ventilation prior to exercise for patients in whom alveolar hypoventilation may be responsible for the exercise limitation, 69 supplementation with creatine particularly in patients with HMSN 123 or dystrophies, 132 neuromuscular electrical stimulation and partial body weight support in patients with incomplete tetraplegia 118 steroids in DMD 72, 133, 134 and theophylline in ALS. 102, 103 However, the balance of risks and benefits of the latter two options need to be weighed carefully, given the potential complications of long-term systemic steroids, and the narrow therapeutic window of theophylline.
Non-exercise related benefits of PR
Depending on the nature and severity of their disease process, patients with neuromuscular diseases may or may not be able to undertake conventional exercise training and/or realize gains in traditionally used outcomes measures such as the 6-min walk test or exercise capacity as measured by cardiopulmonary exercise test. Nevertheless, PR programs provide multidisciplinary and comprehensive interventions, and are not limited to exercise training. 1 For instance, such programs often include patient assessment, education, nutritional intervention and psychosocial support. 1 Accordingly, patients with neuromuscular disease may still benefit from participation in PR, and non-traditional outcomes or goals should be considered. For instance, PR programs could include training on ambulation with assistive walking devices or training with other adaptive assistive equipment to enable the patient to remain functionally independent and enable the patient to live at home rather than in an institution-based setting. PR is an ideal setting to recognize early symptoms related to bulbar involvement, inspiratory and expiratory muscle weakness, and provides a unique opportunity to train and acclimatize patients to the assistive devices and techniques used to ameliorate or palliate those symptoms. These techniques include non-invasive positive pressure ventilation, suction devices, cough-assist devices, training for assisted cough training, flutter devices or vibrating vest, which may be necessary for respiratory muscle support, maintenance of stable gas exchange and protection of the lungs 135 (Table 2 ).
Summary comments
Patients with neuromuscular disorders have significant exercise limitation which may be due to skeletal muscular impairment and respiratory muscle dysfunction. Both peripheral and central components may be responsible for the exercise impairment and both can potentially be improved by PR. The latter consists of aerobic exercise, strength and respiratory muscle training, and can be of significant benefit in patients with neuromuscular diseases with studies showing measurable improvements in quality of life, maximal VO 2 , exercise heart rate, among other parameters, that match the benefits seen with other chronic respiratory disorders. Notwithstanding concerns about the potential of work overload particularly in patients with DM, the best evidence for a benefit of aerobic exercise among patients with neuromuscular disease is seen specifically in patients with muscular disorders (subsuming the dystrophies, myopathies and myositis). The exercise prescription should be tailored to the disease, with respiratory muscle training for patients in whom respiratory muscle weakness or fatigue is contributing to the impairment, and aerobic exercise for those with cardiovascular and/or limb impairment. Additionally, respiratory muscle training may not be beneficial in hypercapnic or severely restricted patients (FVC < 25%). Measures that may prove to compensate for the intrinsic exercise limitations of patients with neuromuscular diseases include use of non-invasive ventilation, creatine supplementation in HMSN, neuroelectrical stimulation in incomplete tetraplegia diaphragm pacing, steroids in DMD, gene therapy to restore sarcolemmal nNOS expression in DMD, vasodilators that compensate for defective NO signaling (in DMD), theophylline in ALS, although the potential benefits of these interventions need to be carefully balanced against their risk and possible side effects.
